MCL-1 Modulating compounds for Cancer Treatment - Archive ouverte HAL Access content directly
Patents Year : 2015

MCL-1 Modulating compounds for Cancer Treatment

Composés modulant MCL-1 utilisés dans le traitement du cancer

(1) , (2) , (2) , (2) , (2) , (2) , (2) , (2) , (2) , (3) , (3)
1
2
3
Not file

Dates and versions

inserm-02545373 , version 1 (17-04-2020)

Identifiers

  • HAL Id : inserm-02545373 , version 1

Cite

Laurent Poulain, Anne-Sophie Voisin-Chiret, Jana Sopkova de Oliveira Santos, Ronan Bureau, Grégory Burzicki, et al.. MCL-1 Modulating compounds for Cancer Treatment. France, Patent n° : WO 2015/132727. 2015. ⟨inserm-02545373⟩
31 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More